Trade Stoke Therapeutics, Inc. - STOK CFD

Trading Conditions

• Type: CFD
• Spread: 0.16
• Long position overnight funding adjustment: -0.02171%
• Short position overnight funding adjustment: -0.00052%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 33.88
• Open: 33.02
• 1-Year Change: 286.2%
• Day's Range: 31.9 - 33.73

What is Stoke Therapeutics, Inc. (STOK)?

Stoke Therapeutics, Inc. is a biotechnology company focused on the development of genetic medicines to treat rare neurological diseases. The company employs a proprietary antisense oligonucleotide platform designed to upregulate gene expression and restore protein levels in patients with genetic disorders. Stoke Therapeutics targets conditions caused by insufficient protein production due to genetic mutations. Its research and development efforts aim to create therapies that address the underlying causes of diseases rather than only managing symptoms. The company collaborates with academic institutions and industry partners to advance its pipeline of therapeutic candidates. Stoke Therapeutics operates within the broader biotechnology sector, concentrating on innovative approaches to treat diseases with significant unmet medical needs. Its work contributes to the expanding field of precision medicine and genetic therapies.

Stoke Therapeutics, Inc. Stock Price Today: Live Overview

The price today is shaped by the current trading session, as Stoke Therapeutics, Inc. trades at $32.91. The intraday range spans from $31.9 to $33.73, with a daily percentage change of -3.3304%.

FAQ: Stoke Therapeutics, Inc. (STOK)

What is the current price of STOK stock?

The current trading price is $32.91.

Does STOK pay dividends?

Stoke Therapeutics, Inc. does not currently pay dividends.

Does STOK have a formal corporate presence or regional headquarters in the UAE?

Stoke Therapeutics, Inc. operates via partners and distributors in the UAE without an official regional office or subsidiary.

What is STOK best known for?

Stoke Therapeutics, Inc. is most famous for its development of RNA-based therapeutics targeting genetic diseases.

What assets are typically shown together with STOK?

Commonly shown alongside STOK: Adaptive Biotechnologies Corporation, Summit Therapeutics Inc, Corbus Pharmaceuticals